Researchers discover how Hepatitis C virus persists for years

A cultured liver cancer cell infected with Hepatitis C. The virus, stained red, surrounds the blue-stained nucleus and is in the process of being reproduced by virus within the cytoplasm. Credit: Takahiro Masaki/UNC Lemon Lab

Hepatitis C virus (HCV) lingers in the human body for years, slowly damaging the liver and leading to liver diseases such as hepatitis, cirrhosis and liver cancer, which is often fatal. Research conducted at the University of North Carolina at Chapel Hill has discovered a mechanism that facilitates the virus achieving this life-long persistence. Chronic HCV infection is the leading cause of liver cancer in the United States.

"Liver cancer is one of the most important causes of cancer mortality worldwide. It's also increasing in rapidly incidence within the United States, due largely to the spread of HCV among Americans in the 60s and 70s," said Stanley M. Lemon, MD, Professor of Medicine at the UNC School of Medicine and a member of the UNC Lineberger Comprehensive Cancer Center.

In a paper published online by Nature Medicine this week, a team led by Dr. Lemon and colleague Daisuke Yamane, DVM, PhD, found that HCV has a sensor function that allows it to be regulated by the oxidative damage to cell membranes that occurs as a byproduct of its replication and the body's response to it. This slows down virus growth when oxidative membrane damage becomes too high, but allows it to resume when the membrane damage is reduced. By auto-regulating its replication in this way, the virus maintains a low profile, helping it escape detection by the immune system. 

"You might consider it like a thermostat," said Dr. Lemon, "one that regulates the growth of the virus like your thermostat regulates the temperature of your house."

The reason why HCV is able to achieve life-long persistence in most individuals who become infected has never been well explained. "What we have done in this paper is to show that the replication of a wide variety of hepatitis C virus strains is uniquely regulated by in the liver. This is an absolutely unique attribute of that sets it apart from similar viruses," said Dr. Lemon.

Oxidative stress occurs when tissue injury generates free radicals, normal biological byproducts that can cause cellular damage when present in excess amounts. This promotes to inflammation and progressive scarring within the liver, leading to further disease like cirrhosis and cancer. Lipid peroxidation occurs on membranes when there are excess free radicals, and that regulates the growth of hepatitis C virus. By reducing its replication, the virus is able to persist at low levels in the liver for years. This slows the damage to the host and helps the virus to escape the attention of the body's immune system.

This autoregulatory circuit has made HCV very difficult to study in the laboratory. The virus does not grow well in cell cultures because of oxidative stress. Dr. Lemon's team have identified mutants of the virus which have lost the ability to be regulated by , and these grow much more efficiently in the laboratory.

"That allows us to use those viruses to test anti-viral drugs and possibly also for vaccine development," said Dr. Lemon.

More information: "Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation." Daisuke Yamane, et al. Nature Medicine (2014) DOI: 10.1038/nm.3610. Received 31 March 2014 Accepted 23 May 2014 Published online 27 July 2014

add to favorites email to friend print save as pdf

Related Stories

Predicting the outcome of hepatitis C virus treatment

Jul 01, 2014

Millions of people throughout the world are infected with hepatitis C virus (HCV), which can lead to cirrhosis of the liver and cancer. Directly acting antiviral agents inhibit viral proteins and have been used to successfully ...

Hepatitis C virus genotype 1 is most prevalent worldwide

Jul 28, 2014

In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journa ...

New focus to combat rising liver disease

Jul 26, 2013

University of Adelaide researchers are investigating how the liver responds to hepatitis C virus (HCV) and why some people can control the virus while others can't. The aim is to find better therapies to combat hepatitis ...

Recommended for you

Where Ebola battles are won

4 hours ago

(HealthDay)—Four hospitals that are home to advanced biocontainment facilities have become America's ground zero in the treatment of Ebola patients.

Depression tied to worse lumbar spine surgery outcomes

7 hours ago

(HealthDay)—Depressive symptoms are associated with poorer long-term outcome in patients undergoing surgery for lumbar spinal stenosis (LSS), according to research published in the Oct. 1 issue of The Sp ...

Ebola death toll edging to 4,900 mark: WHO

7 hours ago

The death toll in the world's worst-ever Ebola outbreak has edged closer to 4,900, while almost 10,000 people have now been infected, new figures from the World Health Organization showed Wednesday.

US to track everyone coming from Ebola nations

8 hours ago

U.S. authorities said Wednesday that everyone traveling into the U.S. from Ebola-stricken nations will be monitored for symptoms for 21 days. That includes returning American aid workers, federal health employees ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Nik_2213
not rated yet Jul 29, 2014
This is why we need an HPC vaccine to complement the HPV vaccine, and enough uptake to crowd these little horrors out of the community.